Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 9/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11831177 | 0.98 | ADRB2 (0.53) | ADRB2PTGS2CYP3A4TSHRHIF1A | |
| SCHEMBL11828601 | 0.98 | ADRB2 (0.53) | ADRB2PTGS2CYP3A4TSHRHIF1A | |
| SCHEMBL2953489 | 0.98 | ADRB2 (0.53) | ADRB2PTGS2CYP3A4TSHRHIF1A | |
| SCHEMBL2952875 | 0.94 | ADRB2 (0.53) | ADRB2PTGS2CYP3A4TSHRHIF1A | |
| Methoxymethane SCHEMBL11832518 | 0.93 | ADRB2 (0.49) | ADRB2PTGS2CYP3A4 | |
| SCHEMBL11301838 | 0.89 | ADRB2 (0.46) | ADRB2PTGS2CYP3A4ADRA1A | |
| SCHEMBL10652423 | 0.86 | PTGS2 (0.51) | ADRB2PTGS2 | |
| SCHEMBL31545144 | 0.84 | ADRB2 (0.50) | ADRB2PTGS2CYP3A4TSHRHIF1A | |
| SCHEMBL21274215 | 0.83 | OPRM1 (0.47) | ADRB2TSHRHIF1AADRA1A | |
| SCHEMBL11830368 | 0.82 | ADRB2 (0.51) | ADRB2PTGS2CYP3A4TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| CN-110383164-B | Inhibitors of photo-thermally induced polymerization for electrophoretic media | 伊英克加利福尼亚有限责任公司 | 2023-05-02 | — | — | CN | disclosed |
| US-20210163387-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2021-06-03 | — | — | US | disclosed |
| US-20210163387-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2021-06-03 | — | — | US | disclosed |
| US-10981850-B2 | One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives | TRUSTEES OF BOSTON UNIVERSITY (US) | 2021-04-20 | — | — | US | disclosed |
| WO-2020214574-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-10-22 | — | — | WO | disclosed |
| US-20200325091-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-10-15 | — | — | US | disclosed |
| US-20200325091-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-10-15 | — | — | US | disclosed |
| US-10585325-B2 | Photo-thermally induced polymerization inhibitors for electrophoretic media | E INK CALIFORNIA, LLC (US) | 2020-03-10 | — | — | US | disclosed |
| CN-110383164-A | Inhibitors of photothermal-induced polymerization for electrophoretic media | 伊英克加利福尼亚有限责任公司 | 2019-10-25 | — | — | CN | disclosed |
| US-3968125-A | Dihydroxyhexahydrodibenzo[b,d]pyrans | ELI LILLY AND COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3960871-A | ANTIDEPRESSANT, ANALGESICS, ANTICONVULSANT ANTI-ANXIETY ACTIVITY | SHARPS ASSOCIATES (US) | 1976-06-01 | — | — | US | disclosed |
| US-3953603-A | Hexahydro-dibenzo[b,d,]pyran-9-ones as psychotropic, particularly anti-depressant drugs | ELI LILLY AND COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3951970-A | ANTIDEPRESSANT, HYPOTENSIVE | SHARPS ASSOCIATES (US) | 1976-04-20 | — | — | US | disclosed |
| US-3946111-A | ANALYGESICS | SHARPS ASSOCIATES (US) | 1976-03-23 | — | — | US | disclosed |
| US-3944673-A | Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs | ELI LILLY AND COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
| US-3941782-A | Heterocyclic esters of benzopyrans | SHARPS ASSOCIATES (US) | 1976-03-02 | — | — | US | disclosed |
| US-3940421-A | Intermediates for the preparation of thienobenzopyrans and thiopyranobenzopyrans | ARTHUR D. LITTLE, INC. (US) | 1976-02-24 | — | — | US | disclosed |
| US-3934024-A | 1,2-DIHYDRO-5,5-DIMETHYL-10-HYDROXY-8-(3-METHYL-2-OCTYL)-3H,5H -THIOPYRANO(2,3-C)(1)BENZOPYRAN) | SHARPS ASSOCIATES (US) | 1976-01-20 | — | — | US | disclosed |
| US-3931232-A | 3-Alkyl xanthene compounds | SMITHKLINE CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981850-B2 | One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives | CNR1, CNR2, SQLE | ADRB2 744/4885PTGS2 911/4885CYP3A4 57/4885 |
| US-20210163387-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | CNR1, CNR2, SQLE | ADRB2 744/4885PTGS2 911/4885CYP3A4 57/4885 |
| US-20200325091-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | CNR1, CNR2, SQLE | ADRB2 744/4885PTGS2 911/4885CYP3A4 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.